How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Novo's third-quarter operating profit rose 27% adjusted and fell 9% reported. Its 2026 outlook moved a third time, to -2% to +2%.

calendar_today November 5, 2026 person EvidInvest Team domain evidinvest-com

Novo Nordisk’s nine-month 6-K puts Q3 sales at DKK 79,195 million, up 4% at CER, and adjusted operating profit at DKK 31,720 million, up 27%, on a base with about DKK 9 billion of 2025 transformation costs; reported operating profit fell 9% after DKK 8.7 billion of impairments. The 2026 outlook is now -2% to +2%. Wegovy pill reached DKK 5,394 million, Ozempic fell 5%, and free cash flow guidance of DKK 60-70 billion sits below the DKK 83.8 billion already reported.

open_in_new Read original post